Advertisement

Topics

Atrium Biotechnologies Company Profile

11:50 EDT 18th June 2018 | BioPortfolio

Atrium Biotechnologies is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. We focus primarily on growing segments of the health and personal care markets which are benefiting from the trend towards healthy living as well as the ageing of the population. We market a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through our highly specialized sales and marketing network, in more than 35 countries, primarily in North America, Europe and Asia.

Location

490 Boston Post Road
Sudbury
Massachusetts
01776
United States of America

Contact

Phone: 1-866-628-2355
Fax: 1-866-866-6661
Email: atrium@atrium-bio.com


News Articles [109 Associated News Articles listed on BioPortfolio]

Atrium Hospitality Notifies Hotel Guests of Compromise

On December 8, 2017, Atrium Hospitality discovered that a workstation at the Holiday Inn Sacramento was potentially impacted by ransomware. Atrium Hospitality immediately removed Read more...

Statement from Southeast Anesthesiology Consultants and Mednax Services, Inc.

Southeast Anesthesiology Consultants (“Southeast”), an affiliate of MEDNAX, Inc. (NYSE:MD) today filed a motion with the North Carolina Business Court seeking a temporary rest...

Deals this week: Refuge Biotechnologies, Attenua, Crescendo Biologics

US-based Refuge Biotechnologies Inc has raised $25m in a series B funding round led by 3SBio and Sequoia China. The...Read More... The post Deals this week: Refuge Biotechnologies, Attenua, Crescendo ...

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Elanix Biotechnologies: Erfolgreiche Studie

Transwell Biotech, ein Partner von Elanix Biotechnologies, schließt eine Phase-I Studie zur Wundbehandlung bei Hauttransplantaten ab. Das Produkt von Transwell kombiniert ein Hydrogel mit kryokonse.....

UNC Health Care and Atrium Health Suspend Discussions

After months of discussions and due diligence, UNC Health Care and Atrium Health have determined that we cannot satisfy our mutual organizational goals through a proposed partners...

Aegea Biotechnologies' next generation nucleic acid clinical diagnostic technologies gets US, Australian & Chinese patents

Aegea Biotechnologies, a biotechnology company, announces the issuance of a collection of patents including US Patent 9,428,747 entitled methods for amplification of nucleic acids utilising hairpin lo...

Drugs and Medications [0 Results]

None

PubMed Articles [98 Associated PubMed Articles listed on BioPortfolio]

Determinants of Reverse Remodeling of the Left Atrium Following Transaortic Myectomy.

In patients with hypertrophic cardiomyopathy (HCM), enlargement of the left atrium (LA) is associated with increased morbidity and mortality due to risk of atrial fibrillation (AF), stroke, and heart ...

A work flow to build and validate patient specific left atrium electrophysiology models from catheter measurements.

Biophysical models of the atrium provide a physically constrained framework for describing the current state of an atrium and allow predictions of how that atrium will respond to therapy. We propose a...

Ethical principles for the use of human cellular biotechnologies.

Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.

Among the potential factors which may contribute to the development and perpetuation of atrial fibrillation, dysregulation of miRNAs has been suggested. Thus in this study, we have quantified the basa...

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

Child With Anomalous Drainage of IVC to Left Atrium

The purpose is to see if any conclusions can be drawn about the uncommon heart defect: anomalous drainage of the inferior vena cava to the left atrium.

Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium

The aim of the study is to compare levels of differnts types of microparticles circulating before and after percutaneous occluding of the left atrium by patients with atrial fibrillation a...

Non - Invasive Evaluation of the Left Atrium Anatomy and Function

The aim of the study is to evaluate the accuracy and reproducibility of the left atrium (LA) anatomy and function in different populations and in patients with atrial fibrillation who have...

Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis

This is a prospective, single center, safety and feasibility trial to evaluate the transplantation of the left atrium and pulmonary veins in patients with pulmonary vein stenosis. Consente...

Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement

This study evaluates the safety and efficiency of surgical prevention of atrial fibrillation in patients with valvular heart disease and left atrium enlargement

Companies [113 Associated Companies listed on BioPortfolio]

Atrium Biotechnologies

Atrium Biotechnologies is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. We focus primarily on growing seg...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Atrium Medical Corporation

Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in ...

Æterna Zentaris Inc

The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Atrium Biotechnologies" on BioPortfolio

We have published hundreds of Atrium Biotechnologies news stories on BioPortfolio along with dozens of Atrium Biotechnologies Clinical Trials and PubMed Articles about Atrium Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atrium Biotechnologies Companies in our database. You can also find out about relevant Atrium Biotechnologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record